from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0223c/-

LFCtreatmentdescriptionclass of inhibitor

0.431

Amikacinug/mL Amikacintranslation

-0.201

Cap5-10ug/mL Capreomycintranslation

-1.124

Rox10-50 ug/mL Roxithromycintranslation

1.247

SM2-5 ug/mL Streptomycintranslation

-1.887

Tet5-10 ug/mL Tetracyclinetranslation

0.548

Rif0.2-5ug/mL Rifampicintranscription

0.397

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.919

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.809

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.124

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.958

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.013

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.657

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.857

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.011

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.339

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.605

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.038

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.210

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.265

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.949

KCN5-20 ug/mL Potassium cyaniderespiration

0.041

NaN30.2-2 mM Sodium aziderespiration

0.214

Nigericin50 uM Nigericinrespiration

0.696

TRC10-150 ug/mL Triclosanrespiration

0.715

TRZ10-25 ug/mL Thioridazinerespiration

-0.943

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.007

menadione6-10 ug/mL Menadionerespiration

2.829

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.186

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.097

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.589

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.335

NRP_1Non-replicating persistence stage 1dosRassociated

0.264

Amp0.2mg/mL AmpicillincellWall

0.081

Cephalexin20-100 ug/mL CephalexincellWall

0.011

Cerulenin0.32-5 ug/mL CerulenincellWall

0.728

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.343

EMB10-20 ug/mL EthambutolcellWall

-0.086

Eta12-40 ug/mL EthionamidecellWall

-0.201

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.238

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.866

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.319

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.306

BZA0.12 mg/mL BenzamidearomaticAmides

-0.037

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.183

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.892

H2O24 mM hydrogen peroxideDNAdamaging

0.385

Levo10 ug/mL LevofloxacinDNAdamaging

-0.069

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.064

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.017

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.191

UVUV-irradiationDNAdamaging

1.240

ARP41-4 ug/mL Antitubercular compound ARP4?

0.382

Antimycin12.5-50 ug/mL Antimycin A?

0.330

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.687

PA_110-50 ug/mL Antitubercular compound PA-1?

0.055

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.544

PA8240.2-2 ug/mL PA-824?

-0.165

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.272

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.573

Verapamil50 uM Verapamil?

0.327

mercaptoethanol2 mM 2-Mercaptoethanol?

0.522

methoxatin10-20 ug/mL Methoxatin?